{"entity":{"type":"insider","cik":"0001762572","url":"/insider/0001762572","json_url":"/insider/0001762572.json","name":"Hoitt Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":7,"first":"2019-04-10","last":"2026-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Hoitt Jason","source":"filing","n_filings":7,"first_seen":"2019-04-10","last_seen":"2026-03-19"}],"transactions":[{"id":5849455,"accession":"0001762572-26-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001762572-26-000006","line_url":"/filing/0001762572-26-000006#line-5","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Patient Officer)","officer_title":"Chief Patient Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1762.0,"shares_display":"1,762","price_per_share":31.2838,"price_display":"31.28","price_state":"stated","total_value":55122.0556,"total_display":"55,122.06","shares_owned_after":10445.0,"shares_owned_after_display":"10,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5849454,"accession":"0001762572-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001762572-26-000006","line_url":"/filing/0001762572-26-000006#line-4","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Patient Officer)","officer_title":"Chief Patient Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139.0,"shares_display":"139","price_per_share":31.7888,"price_display":"31.79","price_state":"stated","total_value":4418.6432,"total_display":"4,418.64","shares_owned_after":10306.0,"shares_owned_after_display":"10,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5849452,"accession":"0001762572-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001762572-26-000006","line_url":"/filing/0001762572-26-000006#line-3","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Patient Officer)","officer_title":"Chief Patient Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30.0,"shares_display":"30","price_per_share":32.85,"price_display":"32.85","price_state":"stated","total_value":985.5,"total_display":"985.50","shares_owned_after":10276.0,"shares_owned_after_display":"10,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5849450,"accession":"0001762572-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001762572-26-000006","line_url":"/filing/0001762572-26-000006#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Patient Officer)","officer_title":"Chief Patient Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1033.0,"shares_display":"1,033","price_per_share":32.7394,"price_display":"32.74","price_state":"stated","total_value":33819.8002,"total_display":"33,819.80","shares_owned_after":12955.0,"shares_owned_after_display":"12,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5849448,"accession":"0001762572-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001762572-26-000006","line_url":"/filing/0001762572-26-000006#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Patient Officer)","officer_title":"Chief Patient Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":748.0,"shares_display":"748","price_per_share":33.3754,"price_display":"33.38","price_state":"stated","total_value":24964.7992,"total_display":"24,964.80","shares_owned_after":12207.0,"shares_owned_after_display":"12,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":7976175,"accession":"0001493152-23-005078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-005078","line_url":"/filing/0001493152-23-005078#line-1","is_derivative":false,"issuer_cik":"0001695357","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001695357","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":10.0012,"price_display":"10.00","price_state":"stated","total_value":45005.4,"total_display":"45,005.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":3304107,"accession":"0001493152-20-004385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-004385","line_url":"/filing/0001493152-20-004385#line-1","is_derivative":false,"issuer_cik":"0001695357","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001695357","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":5.43,"price_display":"5.43","price_state":"stated","total_value":24435.0,"total_display":"24,435.00","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-20","scope":"insider"},{"id":7986886,"accession":"0001562180-19-005056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005056","line_url":"/filing/0001562180-19-005056#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2387.0,"shares_display":"2,387","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":66836.0,"total_display":"66,836.00","shares_owned_after":9970.0,"shares_owned_after_display":"9,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-30","filed_date":"2019-10-02","scope":"insider"},{"id":8418283,"accession":"0001209191-19-042168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-042168","line_url":"/filing/0001209191-19-042168#line-2","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6680.0,"shares_display":"6,680","price_per_share":15.1,"price_display":"15.10","price_state":"stated","total_value":100868.0,"total_display":"100,868.00","shares_owned_after":13257.0,"shares_owned_after_display":"13,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-16","scope":"insider"},{"id":8418278,"accession":"0001209191-19-042168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-042168","line_url":"/filing/0001209191-19-042168#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":16.44,"price_display":"16.44","price_state":"stated","total_value":14796.0,"total_display":"14,796.00","shares_owned_after":12357.0,"shares_owned_after_display":"12,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-16","scope":"insider"},{"id":7927423,"accession":"0001209191-19-040366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-040366","line_url":"/filing/0001209191-19-040366#line-2","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2237.0,"shares_display":"2,237","price_per_share":13.77,"price_display":"13.77","price_state":"stated","total_value":30803.49,"total_display":"30,803.49","shares_owned_after":20087.0,"shares_owned_after_display":"20,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-02","scope":"insider"},{"id":7927418,"accession":"0001209191-19-040366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-040366","line_url":"/filing/0001209191-19-040366#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":2160.0,"total_display":"2,160.00","shares_owned_after":19937.0,"shares_owned_after_display":"19,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-02","scope":"insider"},{"id":7922336,"accession":"0001209191-19-024262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-024262","line_url":"/filing/0001209191-19-024262#line-1","is_derivative":false,"issuer_cik":"0001685071","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001685071","owner_cik":"0001762572","owner_name":"Hoitt Jason","owner_url":"/insider/0001762572","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2387.0,"shares_display":"2,387","price_per_share":8.77,"price_display":"8.77","price_state":"stated","total_value":20933.99,"total_display":"20,933.99","shares_owned_after":22324.0,"shares_owned_after_display":"22,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Officer (Chief Patient Officer)","n_filings":1,"first_seen":"2026-03-19","last_seen":"2026-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001695357","name":"Provention Bio, Inc.","url":"/issuer/0001695357","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2020-03-20","last_seen":"2023-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001685071","name":"Dova Pharmaceuticals Inc.","url":"/issuer/0001685071","role":"Officer (Chief Commercial Officer)","n_filings":4,"first_seen":"2019-04-10","last_seen":"2019-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001762572","retrieved_at":"2026-08-21T09:07:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}